Loading...

Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Italian health companies eye potential in China

Image

03-Feb-16 Italy's medical device companies are looking at the development potential in China, one of the markets where Italy's exports of medical devices have increased the most - by 24% in 2014 - with an export value of EUR310 mn (USD430 mn). Italian companies already present in China include DiaSorin, a biotech group specialized in in-vitro diagnostics. [image: Ambasciata d'Italia Pechino]

Read More

Australia's health spending reaches AUD6,248 per person

Image

02-Feb-16 The cost of Australian healthcare has grown about 4% annually over a decade to AUD6,248 (USD4,449) per person. This was not due to either inflation or population growth rates, which were both factored in to the results. The growth was driven by a range of factors, including medical advances, the ageing population and an increase in people suffering chronic illnesses. [image: Alex Ellinghausen]

Read More

Parkway to build USD70 mn hospital in Yangon

Image

01-Feb-16 Parkway Pantai is set to open a USD70 mn, 250-bed hospital in Yangon, in a bid to capitalise on the largely untapped healthcare market of Myanmar. Parkway Yangon will be Parkway Pantai's first hospital in Myanmar, where demand for quality healthcare is growing. The hospital is expected to open in 2020. [image: IHH]

Read More

Regulations hamstring smart healthcare in Korea

Image

01-Feb-16 At the 2012 Yeosu Expo, SK Telecom showcased its vision for remote healthcare. But "zero progress has been made on the smart health platform” said a manager at SK Telecom this year. “There is nothing we... can do about it because the law prohibiting remote diagnosis and treatment of patients remains unchanged." [image: Joongang Ilbo]

Read More

China’s diabetes boom promises UD23 bn pot for drug makers

Image

30-Jan-16 How big is the potential market for diabetes drugs in China? As big as the entire populations of Australia, Canada and Argentina combined. And it's growing. Only about half of China’s diabetics have been diagnosed, and only 15% of those diagnosed are receiving comprehensive treatment, said Jakob Riis, head of China at Novo Nordisk, the world’s largest insulin maker. [image: AFP / Getty Images]

Read More
Share